NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $326,237 | +0.5% | 3,203 | -0.4% | 0.07% | -1.4% |
| Q2 2023 | $324,506 | +16.7% | 3,216 | +6.4% | 0.07% | -11.4% |
| Q1 2023 | $278,097 | -11.2% | 3,023 | -12.5% | 0.08% | -16.0% |
| Q4 2022 | $313,225 | +5.5% | 3,453 | -11.7% | 0.09% | 0.0% |
| Q3 2022 | $297,000 | -8.0% | 3,910 | +2.4% | 0.09% | +5.6% |
| Q2 2022 | $323,000 | -33.1% | 3,820 | -30.6% | 0.09% | -28.8% |
| Q1 2022 | $483,000 | +2.1% | 5,507 | +1.8% | 0.12% | +7.8% |
| Q4 2021 | $473,000 | +287.7% | 5,412 | +262.7% | 0.12% | +132.0% |
| Q3 2021 | $122,000 | -60.6% | 1,492 | -56.2% | 0.05% | -43.8% |
| Q2 2021 | $310,000 | +33.6% | 3,403 | +25.6% | 0.09% | +14.1% |
| Q1 2021 | $232,000 | +38.1% | 2,709 | +52.3% | 0.08% | -40.0% |
| Q4 2020 | $168,000 | – | 1,779 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |